From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: there are worse hobbies than raising a quarter of a million quid for a great cause like Woodlarks

By Tom Winnifrith | Thursday 30 March 2023


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


But reader Magna Carta says that you all want me to stop mentioning what he terms my "hobby". Matthew's Dog and Catriona will be delighted that I think he can go feck himself, please do feel free to donate HERE. Nearly all of the podcast , as ever, is about companies and I cover: Inland Homes (INL), Moonpig (MOON), Caracal Gold (GCAT), VSA Capital (VSA) and its revenue recognition and the odd company that is Kelso (KLSO). PS did you know that Andrew Monk who runs, what he terms, Very Sexy Andrew, went to Oriel College Oxford? He does mention it now and again.
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 07:04:16